{"disease":{"id":"neurological-disease-without-cognitive-degradation","name":"neurological disease without cognitive degradation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02263235","title":"In Vivo Alzheimer Proteomics","phase":"NA","overall_status":"TERMINATED","enrollment_count":89,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}